XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.4

SEGMENT INFORMATION (Tables)

3 Months Ended

Jan. 31, 2023

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION 

		2023				2022
		For the Three Months Ended January 31,
		2023				2022
Net loss:
CAR-T Therapeutics		$	(911	)		$	(1,611	)
Cancer Vaccines			(958	)			(1,357	)
Anti-Viral Therapeutics			(482	)			(904	)
Other			(3	)			(7	)
Total		$	(2,354	)		$	(3,879	)
Net Loss		$	(2,354	)		$	(3,879	)
Total operating costs and expenses		$	2,556			$	3,880
Less non-cash share-based compensation			(1,063	)			(2,354	)
Operating costs and expenses excluding non-cash share-based compensation		$	1,493			$	1,526
Operating costs and expenses excluding non-cash share based compensation expense:
CAR-T Therapeutics		$	598			$	669
Cancer Vaccines			588				480
Anti-Viral Therapeutics			305				372
Other			2				5
Total		$	1,493			$	1,526
Operating costs and expenses excluding non-cash based compensation		$	1,493			$	1,526

		January 31, 2023				October 31, 2022
Total assets:
CAR-T Therapeutics		$	11,318			$	16,921
Cancer Vaccines			11,098				9,442
Anti-Viral Therapeutics			5,750				3,811
Other			140				238
Total		$	28,306			$	30,412
Total assets		$	28,306			$	30,412

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration